Klotho Neurosciences, Inc. (NASDAQ:KLTO – Get Free Report)’s stock price dropped 8.9% on Wednesday . The stock traded as low as $0.45 and last traded at $0.45. Approximately 337,107 shares changed hands during trading, a decline of 94% from the average daily volume of 5,275,921 shares. The stock had previously closed at $0.49.
Klotho Neurosciences Stock Down 8.9 %
The firm’s 50-day moving average is $0.43.
About Klotho Neurosciences
Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.
Featured Stories
- Five stocks we like better than Klotho Neurosciences
- Comparing and Trading High PE Ratio Stocks
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What is Insider Trading? What You Can Learn from Insider Trading
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What Are the FAANG Stocks and Are They Good Investments?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Klotho Neurosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Klotho Neurosciences and related companies with MarketBeat.com's FREE daily email newsletter.
